Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (31/10/2023) announced the following final list of price concessions for October 2023:
Atomoxetine 10mg capsules
Amisulpride 200mg tablets
Betahistine 16mg tablets
Betahistine 8mg tablets
Betamethasone valerate 0.1% cream
Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops
Carbocisteine 375mg capsules
Carbomer ‘980’ 0.2% eye drops
Cyclizine 50mg/1ml solution for injection ampoules
Dexamfetamine 5mg tablets
Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops 0.2ml unit dose preservative free
Duloxetine 20mg gastro-resistant capsules
Etoricoxib 30mg tablets
Etoricoxib 90mg tablets
Fludrocortisone 100microgram tablets
Itraconazole 100mg capsules
Ketoconazole 2% shampoo
Lamotrigine 100mg tablets
Lamotrigine 200mg tablets
Lamotrigine 25mg tablets
Letrozole 2.5mg tablets
Lorazepam 500microgram tablets
Memantine 10mg/ml oral solution sugar free
Metformin 500mg/5ml oral solution sugar free
Midazolam 10mg/2ml solution for injection ampoules
Morphine sulfate 10mg/1ml solution for injection ampoules
Morphine sulfate 10mg/5ml oral solution
Pantoprazole 40mg gastro-resistant tablets
Paracetamol 250mg/5ml oral suspension sugar free
Paracetamol 500mg effervescent tablets
Permethrin 5% cream
Quetiapine 25mg tablets
Riluzole 50mg tablets
Ropinirole 2mg tablets
Rosuvastatin 5mg tablets
Sodium chloride 0.9% nebuliser liquid 2.5ml unit dose ampoules
Tacrolimus 0.1% ointment
Tacrolimus 0.1% ointment
Timolol 0.5% eye drops
Zonisamide 100mg capsules
For the full list of price concessions granted for October 2023, please visit our webpage: cpe.org.uk/priceconcessions
No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
Please subscribe to our mailing list to receive email updates of any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions) To hear more on how the current price concessions system operates, pharmacy teams can now access a recording of our recent Medicines Supply and Concessions Briefing webinar here.
Improvements to the price concession system
Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by DHSC in second half of 2022, it was agreed that an urgent review of the price concession setting system would take place.
Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.
One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.
Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us. We are also continuing to work with DHSC on how a ‘retrospective increased payment’ may apply, where appropriate. Further information regarding this concession ‘top-up’ mechanism will be issued once details are finalised.